Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Lincomycin HCL Market by Type (Injection, Oral), By Application (Children, Adults) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Lincomycin HCL Market by Type (Injection, Oral), By Application (Children, Adults) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 139344 3300 Pharma & Healthcare 377 231 Pages 4.7 (35)

Market Overview:

The global lincomycin HCL market is expected to grow at a CAGR of 3.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of infectious diseases, rising demand for antibiotics, and growing awareness about lincomycin HCL. Based on type, the global lincomycin HCL market is segmented into injection and oral segments. The injection segment is expected to account for a larger share of the global market in 2018 owing to its higher usage rates as compared to oral formulations. However, the oral segment is projected to grow at a higher CAGR during the forecast period due its lower cost and easy availability as compared to injectable formulations. Based on application, the global lincomycin HCL market is divided into children’s applications and adult applications segments. The children’s applications segment accounted for a larger share of the overall market in 2017 due high incidence rates of infections among pediatric population across regions worldwide.

Global Lincomycin HCL Industry Outlook

Product Definition:

Lincomycin hydrochloride is a lincosamide antibiotic used to treat infections caused by bacteria. It works by stopping the growth of bacteria.


Injection is a Gram-positive bacteria that can be administered orally, by injection or as a cream. It has the ability to grow in the presence of oxygen and different nutrients. The most commonly used species are Listeria innocua, Listeria erythraeoplastica and Escherichia coli.


Oral is a type of antibiotic drug that works by killing the bacteria in the body. There are different types of antibiotics such as topical, injectable, and oral. Lincomycin HCL is an antibiotic used for treatment of bacterial infections in the lungs (pneumonia), urinary tract, and other areas affecting mainly kidney function. It may also be used to treat some ear infections and sinusitis cases along with some skin diseases like impetigo (contact dermatitis).

Application Insights:

The adults segment held the largest share of over 70.0% in 2017. The application of lincomycin is more common among adult patients as compared to children owing to higher incidence of infections caused by Staphylococcus aureus and other co-infections such as HIV, tuberculosis and hepatitis. According to the U.S Department of Health & Human Services, every year around 60 million people are diagnosed with some form of infection due to S. aureus which results in over 23000 deaths across the world which places significant demand onlincomycin for treatment globally as well as locally during 2018-2030 period globally regarding this matter an open access paper states that approximately 1125 deaths were reported due to methicillin-resistant S.

Regional Analysis:

Asia Pacific dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing antibiotic-resistant infections, rising healthcare expenditure, and growing awareness about Lincomycin HCL treatment options among patients & physicians. In addition, favorable reimbursement policies for oral drugs are also expected to drive regional growth over the forecast period.

Europe accounted for a significant share of revenue in 2017 owing to high prevalence of multi-drug resistant tuberculosis (MDR TB) and extensively drug-resistant (XDR) tuberculosis that require highly effective antibiotics such as lincomycin hydrochloride tablets for treatment & prevention of MDR TB and XDRTB disease transmission.

Growth Factors:

  • Increasing prevalence of infectious diseases: The increasing prevalence of infectious diseases is one of the major growth drivers for the lincomycin HCL market. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, and parasites. These infections can cause a wide range of symptoms, depending on the site and severity of infection. The increasing incidence of infectious diseases is due to various factors such as changing lifestyles, growing population, and global travel. This is expected to drive the demand for lincomycin HCL in the coming years.
  • Rising demand for antibiotics: The rising demand for antibiotics is another major growth driver for the lincomycin HCL market. Antibiotics are drugs that are used to treat infections caused by bacteria or other microorganisms such as parasites and fungi). They work by killing or stopping the growth of these organisms. The increasing use of antibiotics is due to various factors such as rising incidence of bacterial infections, growing awareness about antibiotic resistance, and expanding healthcare infrastructure in developing countries. This is expected to drive the demand for lincomycin HCL in future years..

Scope Of The Report

Report Attributes

Report Details

Report Title

Lincomycin HCL Market Research Report

By Type

Injection, Oral

By Application

Children, Adults

By Companies

Pfizer, Nanyang PuKang, Henan Topfond, Anhui Wanbei, NCPC, SuZhou NO.4 Phamaceutical Factory, ...

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Lincomycin HCL Market Report Segments:

The global Lincomycin HCL market is segmented on the basis of:


Injection, Oral

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Children, Adults

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Pfizer
  2. Nanyang PuKang
  3. Henan Topfond
  4. Anhui Wanbei
  5. NCPC
  6. SuZhou NO.4 Phamaceutical Factory
  7. ...

Global Lincomycin HCL Market Overview

Highlights of The Lincomycin HCL Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Injection
    2. Oral
  1. By Application:

    1. Children
    2. Adults
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Lincomycin HCL Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Lincomycin HCL Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Lincomycin HCL is a type of antibiotic. It is used to treat infections caused by bacteria.

Some of the major players in the lincomycin hcl market are Pfizer, Nanyang PuKang, Henan Topfond, Anhui Wanbei, NCPC, SuZhou NO.4 Phamaceutical Factory.

The lincomycin hcl market is expected to register a CAGR of 3.5%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Lincomycin HCL Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Lincomycin HCL Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Lincomycin HCL Market - Supply Chain
   4.5. Global Lincomycin HCL Market Forecast
      4.5.1. Lincomycin HCL Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Lincomycin HCL Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Lincomycin HCL Market Absolute $ Opportunity

5. Global Lincomycin HCL Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Lincomycin HCL Market Size and Volume Forecast by Type
      5.3.1. Injection
      5.3.2. Oral
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Lincomycin HCL Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Lincomycin HCL Market Size and Volume Forecast by Application
      6.3.1. Children
      6.3.2. Adults
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Lincomycin HCL Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Lincomycin HCL Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Lincomycin HCL Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Lincomycin HCL Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Lincomycin HCL Demand Share Forecast, 2019-2029

9. North America Lincomycin HCL Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Lincomycin HCL Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Lincomycin HCL Market Size and Volume Forecast by Application
      9.4.1. Children
      9.4.2. Adults
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Lincomycin HCL Market Size and Volume Forecast by Type
      9.7.1. Injection
      9.7.2. Oral
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Lincomycin HCL Demand Share Forecast, 2019-2029

10. Latin America Lincomycin HCL Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Lincomycin HCL Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Lincomycin HCL Market Size and Volume Forecast by Application
      10.4.1. Children
      10.4.2. Adults
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Lincomycin HCL Market Size and Volume Forecast by Type
      10.7.1. Injection
      10.7.2. Oral
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Lincomycin HCL Demand Share Forecast, 2019-2029

11. Europe Lincomycin HCL Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Lincomycin HCL Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Lincomycin HCL Market Size and Volume Forecast by Application
      11.4.1. Children
      11.4.2. Adults
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Lincomycin HCL Market Size and Volume Forecast by Type
      11.7.1. Injection
      11.7.2. Oral
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Prduct Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Lincomycin HCL Demand Share, 2019-2029

12. Asia Pacific Lincomycin HCL Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Lincomycin HCL Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Lincomycin HCL Market Size and Volume Forecast by Application
      12.4.1. Children
      12.4.2. Adults
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Lincomycin HCL Market Size and Volume Forecast by Type
      12.7.1. Injection
      12.7.2. Oral
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Lincomycin HCL Demand Share, 2019-2029

13. Middle East & Africa Lincomycin HCL Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Lincomycin HCL Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Lincomycin HCL Market Size and Volume Forecast by Application
      13.4.1. Children
      13.4.2. Adults
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Lincomycin HCL Market Size and Volume Forecast by Type
      13.7.1. Injection
      13.7.2. Oral
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Lincomycin HCL Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Lincomycin HCL Market: Market Share Analysis
   14.2. Lincomycin HCL Distributors and Customers
   14.3. Lincomycin HCL Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Pfizer Overview Financials Developments Strategic Outlook
      14.4.2. Nanyang PuKang Overview Financials Developments Strategic Outlook
      14.4.3. Henan Topfond Overview Financials Developments Strategic Outlook
      14.4.4. Anhui Wanbei Overview Financials Developments Strategic Outlook
      14.4.5. NCPC Overview Financials Developments Strategic Outlook
      14.4.6. SuZhou NO.4 Phamaceutical Factory Overview Financials Developments Strategic Outlook
      14.4.7. ... Overview Financials Developments Strategic Outlook
      14.4.8. COMPANY8 Overview Financials Developments Strategic Outlook
      14.4.9. COMPANY9 Overview Financials Developments Strategic Outlook
      14.4.10. COMPANY 10 Overview Financials Developments Strategic Outlook
      14.4.11. COMPANY 11 Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us